Navigation Links
International patient alliance to fund Spanish Friedreich's ataxia gene-therapy project
Date:1/28/2014

Barcelona, Tuesday 28 January 2014.- The gene therapy-based research project to tackle Friedreich's ataxia launched in November in labs at the Institute for Research in Biomedicine (IRB), in Barcelona, and the "Centro de Biologa Molecular Severo Ochoa" (CBMSO), in Madrid, has received 100,000 US$ per year for two years from the Friedreich's Ataxia Research Alliance (FARA). FARA is one of the main patients' organisations in the United States and since 1998 it has provided a rigorous and solid funding programme for research projects all over the world that aim to tackle Friedreich's ataxia, a rare and serious hereditary neurodegenerative disease for which only palliative treatments are currently available.

The peculiarity is that the idea of the project came from those affected by the disease, patients and relatives, who, in their endeavours to find a cure got in touch with basic research groups in order to start a long-term project. The GENEFA Platform, in close collaboration with FEDAES and the BabelFAmily, started fund-raising efforts in May 2013, and in November signed an agreement with IRB and CMBSO, headed by Joan Guinovart, director of the IRB, and Margarita Salas, president of the "Fundacin Severo Ochoa".

"The monthly subscriptions of members of the GENEFA Platform form the basis of the funding; however, the organisation has also held a wide range of fund-raising events and activities and has been supported by donations from companies, associations, and relatives and friends of those affected by Friedreich's ataxia. We are all working hard towards finding a cure and now the collaboration of FARA guarantees the funding required for this purpose," explains Juan Carlos Baiges, on behalf of the members of the Platform.

The project involves the research groups headed by Javier Daz-Nido at the CBMSO, an international expert in gene therapy and Friedreich's ataxia, and Ernest Giralt at IRB, an international authority on the design of transporters, such as nanoparticles, that can carry drugs into the brain and thus overcome the blood-brain barrier. Patients with this ataxia inherit a mutated version of the frataxin gene, which causes neurodegeneration. The project seeks to rescue this defect in cells of the central nervous system.

Jennifer Farmer, executive director of FARA, explains "when you are working on a rare disease, critical resources, such as funding, are quite small so it is imperative that FARA and other global groups with an interest in supporting and advancing research in Friedreich's ataxia work together". "We can't afford to duplicate effort or compete." She goes on to add that "we are proud to give our support to the solid scientific project led by doctors Daz-Nido and Giralt to identify new therapies and at the same time to strike up an alliance with patients in Spain."


'/>"/>

Contact: Sònia Armengou
armengou@irbbarcelona.org
34-934-037-255
Institute for Research in Biomedicine (IRB Barcelona)
Source:Eurekalert  

Related biology news :

1. Island Biology 2014: An International Conference on Island Evolution, Ecology, and Conservation
2. FASEB announces 2014 Science Research Conference: 2nd International Conference on Retinoids
3. International experts swarm to London for bee health summit
4. International deal to screen potential cancer drugs using DNA barcodes
5. The International Society for Stem Cell Research announces its 2014 award recipients
6. Story of human regeneration wins international physics journalism prize
7. CROS NT Ltd Announces Acquisition of MDSL International Ltd.
8. EcoHealth Alliance and Bat Conservation International forge partnership to work on global bat conservation and public health issues
9. International team completes systematic, genomic study of cervical cancer
10. World e-waste map reveals national volumes, international flows
11. First International Bioenergy Conference brings together world-leading experts
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
International patient alliance to fund Spanish Friedreich's ataxia gene-therapy project
(Date:6/21/2016)... VANCOUVER, British Columbia , June 21, 2016 ... been appointed to the new role of principal ... has been named the director of customer development. ... , NuData,s chief technical officer. The moves reflect ... development teams in response to high customer demand ...
(Date:6/9/2016)... Paris Police Prefecture and ... ensure the safety of people and operations in several locations ... Teleste, an international technology group specialised in broadband ... its video security solution will be utilised by ... across the country. The system roll-out is scheduled for the ...
(Date:6/2/2016)... , June 2, 2016 Perimeter ... Platforms, Unmanned Systems, Physical Infrastructure, Support & Other Service  ... visiongain offers comprehensive analysis of the global ... market will generate revenues of $17.98 billion in 2016. ... DVTEL Inc, a leader in software and hardware technologies ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... , June 23, 2016 A person commits ... the crime scene to track the criminal down. ... U.S. Food and Drug Administration (FDA) uses DNA evidence to ... Sound far-fetched? It,s not. The FDA has ... to support investigations of foodborne illnesses. Put as simply as ...
(Date:6/23/2016)... NEW YORK , June, 23, 2016  The ... students to envision new ways to harness living systems ... of Modern Art (MoMA) in New York ... more than 130 participating students, showcased projects at MoMA,s ... included Paola Antonelli , MoMA,s senior curator of ...
(Date:6/23/2016)... ... June 23, 2016 , ... In a new case ... Denmark detail how a patient who developed lymphedema after being treated for breast cancer ... could change the paradigm for dealing with this debilitating, frequent side effect of cancer ...
(Date:6/23/2016)... On Wednesday, June 22, 2016, the NASDAQ Composite ... Jones Industrial Average edged 0.27% lower to finish at 17,780.83; ... has initiated coverage on the following equities: Infinity Pharmaceuticals Inc. ... NKTR ), Aralez Pharmaceuticals Inc. (NASDAQ: ARLZ ), ... more about these stocks by accessing their free trade alerts ...
Breaking Biology Technology: